Concomitant use may lower systemic exposures and reduce effectiveness of immunoglobulin products. Closely monitor for reduced effectiveness.
Source: NLP:rozanolixizumab
Immunoglobulin Products Interactions
1 interaction on record
1 interaction on record
Concomitant use may lower systemic exposures and reduce effectiveness of immunoglobulin products. Closely monitor for reduced effectiveness.
Source: NLP:rozanolixizumab